tiprankstipranks

New Portfolio - New Portfolio

Kamal Raghav

New Portfolio
Individual Investor
Ranked #39,506 out of 779,996 TipRanks' Investors
Success Rate
51%
56 out of 110
profitable transactions
Average Return
68.41%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▼ 2.68%
6-Month Return▲ 2.01%
12-Month Return▲ 24.68%
YTD Return▼ 1.76%
Total Return▲ 36.87%

Best Trade

Opened at
Closed at-
Gain▲ 1606.21%

Bio

I'm just a nobody

Performance

26.04%0-26.04%
▲ 9.79%
▲ 3.53%
▼ 3.43%
Jun 2024
▲ 8.13%
▲ 1.21%
▲ 7.22%
Jul 2024
▼ 13.14%
▲ 2.34%
▼ 0.80%
Aug 2024
▲ 2.93%
▲ 2.10%
▲ 1.45%
Sep 2024
▲ 10.00%
▼ 0.89%
▼ 3.73%
Oct 2024
▲ 26.04%
▲ 5.96%
▲ 9.67%
Nov 2024
▲ 5.96%
▼ 2.41%
▼ 4.70%
Dec 2024
▲ 5.80%
▼ 0.95%
▼ 1.76%
Jan 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 9.79%▲ 3.53%▼ 3.43%
▲ 8.13%▲ 1.21%▲ 7.22%
▼ 13.14%▲ 2.34%▼ 0.80%
▲ 2.93%▲ 2.10%▲ 1.45%
▲ 10.00%▼ 0.89%▼ 3.73%
▲ 26.04%▲ 5.96%▲ 9.67%
▲ 5.96%▼ 2.41%▼ 4.70%
▲ 5.80%▼ 0.95%▼ 1.76%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Ionis Pharmaceuticals
1.1%
▼ 4.35%
1
Open
Dec 24, 2024
Regulus
1.1%
▼ 15.58%
1
Open
Dec 24, 2024
Actinium Pharmaceuticals
1.1%
▲ 3.28%
1
Open
Dec 24, 2024
Bioxcel Therapeutics
1.1%
▲ 9.12%
1
Open
Dec 24, 2024
Rocket Pharmaceuticals
1.1%
▼ 8.13%
1
Open
Dec 24, 2024
Aemetis
1.1%
▲ 6.08%
1
Open
Dec 24, 2024
Humacyte
1.1%
▼ 2.66%
1
Open
Dec 24, 2024
Iteris
▲ 56.99%
2
Close
Oct 31, 2024
Osisko Mining
▲ 41.02%
2
Close
Oct 29, 2024
G1 Therapeutics
▼ 70.43%
2
Close
Sep 17, 2024
Agile Therapeutics
▼ 99.97%
2
Close
Aug 26, 2024
Calamp
▼ 99.96%
2
Close
Aug 01, 2024
Curo Group Holdings
▼ 99.46%
2
Close
Jul 19, 2024
Gamida Cell
▼ 99.68%
2
Close
May 24, 2024
SP Plus
▲ 179.45%
2
Close
May 15, 2024
Kaman
▲ 32.54%
2
Close
Apr 18, 2024
Orchard Therapeutics
▼ 75.51%
2
Close
Jan 24, 2024
Celyad Oncology
▼ 93.95%
2
Close
Oct 25, 2023
Zynerba Pharmaceuticals
▼ 78.48%
2
Close
Oct 10, 2023
Aerojet Rocketdyne Holdings
▲ 63.80%
2
Close
Jul 28, 2023